Carvedilol Tablet, Film Coated
Product Images NDC 50090-6742

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-6742). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 01)

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 01)
Chemical structure diagram of carvedilol, showing its molecular framework with labeled functional groups and rings.*
FDA Label Image

Carvedilol Tablets (2c528763 Eac4 4001 A828 95a981ad29b1 02)

Carvedilol Tablets (2c528763 Eac4 4001 A828 95a981ad29b1 02)
A line graph comparing percent mortality over a 21-month period between two groups, one labeled 'Carvedilol' and the other 'Placebo'. The y-axis is labeled '% Mortality' and the x-axis is labeled 'Months'. The Carvedilol group shows lower mortality than the Placebo group. A p-value of 0.0014 is indicated on the graph.*
FDA Label Image

Carvedilol Tablets (2c528763 Eac4 4001 A828 95a981ad29b1 03)

Carvedilol Tablets (2c528763 Eac4 4001 A828 95a981ad29b1 03)
A forest plot illustrating hazard ratios for various patient subgroups including gender, age groups, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and use of spironolactone. The chart shows point estimates with confidence intervals comparing relative risk across these categories.*
FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 04)

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 04)
A line graph depicting the percentage mortality over time in months, comparing Carvedilol with placebo. The y-axis shows % mortality up to 30%, and the x-axis shows time in months up to 24. The graph displays two curves, one for Carvedilol showing lower mortality than the placebo group. A p-value of 0.03 is indicated.*
FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 05)

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 05)
A forest plot chart showing hazard ratios across different subgroups of patients. The subgroups include age, gender, timing of myocardial infarction randomization, prior use of Ivabradine, Killip class, thrombolytic status, PTCA for MI status, history of congestive heart failure, diuretics use, angina presence, hypertension status, diabetes status, heart rate categories, and systolic blood pressure categories. Each subgroup displays a point estimate and confidence intervals for the hazard ratio.*
FDA Label Image

Label Image (Lbl500906742)

Label Image (Lbl500906742)
Carvedilol 6.25 mg film-coated tablet label from A-S Medication Solutions, Libertyville, IL. The label shows dosage strength 6.25 mg, packaging of 60 tablets, storage instructions to keep at 68 to 77 degrees Fahrenheit and protect from moisture, and identifies carvedilol as the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.